Cord blood transplantation combined with rituximab for Wiskott-Aldrich syndrome with autoimmune thrombotic thrombocytopenic purpura

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 1, 2013, Pages 226-227

  Toyoda, Hidemi ^a   Azuma, Eiichi ^a   Kawasaki, Yukako ^a   Iwasa, Tadashi ^a   Ohashi, Hiroyuki ^a   Otsuki, Shoichiro ^a   Iwamoto, Shotaro ^a   Hirayama, Masahiro ^a   Itoh Habe, Naomi ^a   Wada, Hideo ^a   Kondo, Mineo ^a   Keida, Yoshitaka ^b   Ito, Tsuyoshi ^b   Komada, Yoshihiro ^a  

^a MIE UNIVERSITY   (Japan)

^b TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FOSCARNET; GANCICLOVIR; METHOTREXATE; RITUXIMAB; TACROLIMUS; VALGANCICLOVIR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; WISKOTT ALDRICH SYNDROME PROTEIN;

CASE REPORT; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS RETINITIS; DRUG DOSE ESCALATION; GENE SEQUENCE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; KARNOFSKY PERFORMANCE STATUS; LETTER; MALE; MYELOABLATIVE CONDITIONING; PLASMAPHERESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REFRACTORY THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS LOAD; WISKOTT ALDRICH SYNDROME;

EID: 84882859562     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.01.040     Document Type: Article

References (8)

1. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006;117:725-38.
2. Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood 2011;118:1675-84.
3. Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. JAllergy Clin Immunol 2008;122:1087-96.
4. Kremer Hovinga JA, Vesely SK, Terrell DR, Lämmle B, George JN. Survivalandrelapse in patients with thrombotic thrombocytopenic purpura. Blood 2010;115:1500-11.
5. Kawasaki Y, Toyoda H, Otsuki S, Iwasa T, Iwamoto S, Azuma E, et al. A novel Wiskott-Aldrich syndrome protein mutation in an infant with thrombotic thrombo-cytopenic purpura. Eur J Haematol 2013;90:164-8.
6. Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 2003;111:e622-7.
7. Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, et al. Clinical course of patients with WASP gene mutations. Blood 2004;103:456-64.
8. Kim JJ, Thrasher AJ, Jones AM, Davies EG, Cale CM. Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency. Br J Haematol 2007; 138:94-6.